Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).

Eric L Simpson Vimal H Prajapati Yael A Leshem Raj Chovatiya Marjolein de Bruin-Weller Pamela Guglielmini Andrew E Pink Brian M Calimlim Wan-Ju LeeHenrique TeixeiraBarry Ladizinski Xiaofei Hu Yang Yang Yingyi Liu Meng Liu Ayman Grada Andrew M Platt Jonathan Ian Silverberg

Published in: Dermatology and therapy (2024)

ClinicalTrials.gov identifiers, NCT03569293 and NCT03607422.

Keyphrases